RELAPSED HEMATOLOGIC MALIGNANCY
Clinical trials for RELAPSED HEMATOLOGIC MALIGNANCY explained in plain language.
Never miss a new study
Get alerted when new RELAPSED HEMATOLOGIC MALIGNANCY trials appear
Sign up with your email to follow new studies for RELAPSED HEMATOLOGIC MALIGNANCY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill combo shows promise for tough brain cancer
Disease control Recruiting nowThis study tests an experimental oral drug called emavusertib, taken alone or with another drug (ibrutinib), in adults with a rare brain lymphoma that has returned or stopped responding to prior therapy. The goal is to find safe doses and see if the combination can shrink tumors …
Matched conditions: RELAPSED HEMATOLOGIC MALIGNANCY
Phase: PHASE1, PHASE2 • Sponsor: Curis, Inc. • Aim: Disease control
Last updated May 22, 2026 14:05 UTC
-
Smart tumor testing guides lifesaving choices for young cancer patients
Knowledge-focused Recruiting nowThis study creates a team of experts across Europe to help doctors pick the best available treatment for children and young adults whose blood cancer has come back or not responded to therapy. By analyzing each patient's unique tumor markers, the team gives personalized advice on…
Matched conditions: RELAPSED HEMATOLOGIC MALIGNANCY
Sponsor: Princess Maxima Center for Pediatric Oncology • Aim: Knowledge-focused
Last updated May 26, 2026 10:35 UTC